在SCCmec转化过程中,需要在混合生物膜中使用活体供体细胞
Mais Maree1, Yuri Ushijima1, Pedro B Fernandes1
1Institute of Medicine, University of Tsukuba, Japan.
Biofilm
|March 5, 2024
概括
活体供体细胞显著改善了通过自然转化在生物膜中转移葡萄球菌带染色体mec (SCCmec). 这种增强的方法有助于理解MRSA的出现和基因转移在Staphylococcus aureus.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 抗甲素黄金葡萄球菌 (MRSA) 的出现与葡萄球菌带染色体mec (SCCmec) 的水平基因转移有关.
- 之前的研究表明,低频SCCmec通过自然转化通过热杀死生物膜中的供体转移.
研究的目的:
- 为了提高SCCmec自然转化的SCCmec生物膜的效率.
- 调查Ccr-attB系统在SCCmec转移中的作用.
- 评估使用活体供体细胞对基因转移效率的影响.
主要方法:
- 在生物膜中共培养活着的MRSA或耐甲林凝固性阴性葡萄球菌供体细胞与对甲林敏感的金黄色葡萄球菌接收细胞.
- 开发一种改进的自然转化试验.
- 分析删除ccrAB复合酶基因对SCCmec转移频率的影响.
主要成果:
- 使用活供体细胞实现了高达10^-2的SCCmec转换频率,这与以前的方法相比是显著的改进.
- 证明Ccr-attB系统对SCCmec转移至关重要,ccrAB删除减少频率约30倍.
- 从耐药菌株成功转移到敏感的黄金葡萄球菌接受者.
- 在使用活体捐赠细胞时观察到其他等离子体和染色体基因的增强转化.
结论:
- 自然转变是黄金葡萄球菌的一个关键进化机制,有助于MRSA的出现.
- 在共同培养的生物膜中利用活体供体细胞大大提高了SCCmec的传输效率.
- 在SCCmec.的自然转化过程中,Ccr-attB系统起着至关重要的作用.
更多相关视频
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
7.8K
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.4K
相关概念视频
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
